Category: Challenges and Solutions for Medtech Startups

If you typed Latam Research Associates (LR Associates, LRA, lrassociates.health) into a search box, you are probably vetting a site partner for a clinical study in Panama. This article uses only what is public about Latam Research Associates (lrassociates.health) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What Latam Research Associates publishes

Latam Research Associates Corp. is a Panama corporation (sociedad anónima) registered in Panama City on May 5, 2025, listed as active in the public company registry (registry listing). Its website, lrassociates.health, titled “LR Associates”, showed an email sign-up form when reviewed in November 2026; we found no published services, team, study list or address there. Outreach from the company describes access to affiliated doctors and medical groups in Panama.

A search of ClinicalTrials.gov in November 2026 returned no study records mentioning “Latam Research Associates” (query). Based on its own description, it presents as a physician and site network intermediary rather than a full-service CRO.

Latam Research Associates vs bioaccess®

Where each one fits

If you only need introductions to physicians in Panama, a referral network like Latam Research Associates may be one option; ask it for its investigator list, prior sponsors and executed studies before you commit.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site network on your list, including Latam Research Associates, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Panama. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the Latam Research Associates website, the Panama company registry and ClinicalTrials.gov linked above, reviewed for bioaccess® competitive research (Nov 2026). No invented sponsors, prices or contacts.

If you typed Soluciones Integrales para Investigación Clínica into a search box, you are probably building a CRO or site shortlist for Paraguay. This article uses only what is public about Soluciones Integrales para Investigación Clínica (www.sitioresearch.org) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What Soluciones Integrales para Investigación Clínica publishes

Soluciones Integrales para Investigación Clínica en Paraguay describes itself on its site as a pioneering organization specializing in clinical research in Paraguay, with knowledge of the country’s regulatory, medical and operational environment.

Soluciones Integrales para Investigación Clínica vs bioaccess®

Where each one fits

If you need local clinical research support in Paraguay, Soluciones Integrales’ published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Soluciones Integrales para Investigación Clínica, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Paraguay. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the Soluciones Integrales para Investigación Clínica public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed Research & Data Processing (RDP) into a search box, you are probably building a CRO or site shortlist for Venezuela. This article uses only what is public about Research & Data Processing (RDP LinkedIn) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What Research & Data Processing publishes

Research & Data Processing, C.A. (RDP) is a Caracas-based company providing clinical data management, CDISC-SDTM data tabulation and biostatistics for clinical trials. It has announced CDISC Gold Membership.

Research & Data Processing vs bioaccess®

Where each one fits

If you need clinical data management or CDISC-SDTM conversion, RDP’s published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Research & Data Processing, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Venezuela. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the Research & Data Processing public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed Registrum Group into a search box, you are probably building a CRO or site shortlist for Dominican Republic. This article uses only what is public about Registrum Group (registrumgroup.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What Registrum Group publishes

Registrum Group describes itself as a Dominican site management organization that conducts clinical trials, selects investigators and sites, reviews protocols, plans recruitment and offers regulatory services and clinical research advice in the Dominican Republic.

Registrum Group vs bioaccess®

Where each one fits

If you need site management and regulatory support in the Dominican Republic, Registrum’s published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Registrum Group, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Dominican Republic. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the Registrum Group public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed Accuracy Research into a search box, you are probably building a CRO or site shortlist for Ecuador. This article uses only what is public about Accuracy Research (www.accuracyresearch.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What Accuracy Research publishes

Accuracy Research presents itself as a CRO company in Latin America based in Quito, Ecuador. Its site covers clinical trials, decentralized trials, pharmacovigilance, regulatory affairs and quality topics.

Accuracy Research vs bioaccess®

Where each one fits

If you need an Ecuador-based CRO for drug or vaccine trials, Accuracy Research’s published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Accuracy Research, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Ecuador. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the Accuracy Research public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed STEER into a search box, you are probably building a CRO or site shortlist for Ecuador. This article uses only what is public about STEER (ARCSA register of contract research organizations) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What STEER publishes

STEER Centro de Administración y Asesoría en Investigación Clínica Cía. Ltda. is a Quito-based company listed in the national register of contract research organizations kept by Ecuador’s regulator ARCSA.

STEER vs bioaccess®

Where each one fits

If you need an ARCSA-registered local organization for clinical research administration in Ecuador, STEER’s registration matches.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including STEER, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Ecuador. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the STEER public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed TRIAL (Therapeutic Research Institute and Lab) into a search box, you are probably building a CRO or site shortlist for Guatemala. This article uses only what is public about TRIAL (trialresearch.org) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What TRIAL publishes

TRIAL describes itself as a CRO and site management organization (SMO) in Guatemala, offering regulatory services, investigational product management including storage and distribution, research site support and continuing education.

TRIAL vs bioaccess®

Where each one fits

If you need a Guatemala-based CRO/SMO for regulatory, logistics and site support, TRIAL’s published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including TRIAL, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Guatemala. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the TRIAL public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed ICIC (Instituto Costarricense de Investigaciones Clínicas) into a search box, you are probably building a CRO or site shortlist for Costa Rica. This article uses only what is public about ICIC (ClinicalTrials.gov NCT04497610) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What ICIC publishes

The Instituto Costarricense de Investigaciones Clínicas (ICIC) is a clinical research institution in San José, Costa Rica. It is the lead sponsor on ClinicalTrials.gov of a study of a breath-analyzer system for SARS-CoV-2 detection (NCT04497610).

ICIC vs bioaccess®

Where each one fits

If you need a clinical research institution in Costa Rica, ICIC’s public record matches.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including ICIC, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Costa Rica. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the ICIC public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed QPharma Research into a search box, you are probably building a CRO or site shortlist for Dominican Republic. This article uses only what is public about QPharma Research (qpharmaresearch.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What QPharma Research publishes

QPharma Research describes itself as a Caribbean research partner based in the Dominican Republic, focused on delivering human biospecimens (tissue, FFPE, blood and other samples) with clinical data for research, through prospective and archived collections.

QPharma Research vs bioaccess®

Where each one fits

If you need human biospecimens or research support in the Caribbean, QPharma’s published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including QPharma Research, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Dominican Republic. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the QPharma Research public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

If you typed VaxTrials (now Emmes) into a search box, you are probably building a CRO or site shortlist for Panama. This article uses only what is public about VaxTrials (Emmes announcement) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What VaxTrials publishes

VaxTRIALS was a Panama City-based CRO specializing in vaccine trials in Latin America and the Philippines; Emmes announced its acquisition in 2023. Vaxtrials S.A. appears on ClinicalTrials.gov as sponsor or collaborator on polio vaccine studies supported by the Gates Foundation (e.g. NCT02111135).

VaxTrials vs bioaccess®

Where each one fits

If you need vaccine or infectious-disease trial capacity in Latin America, Emmes/VaxTRIALS’ public record matches.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including VaxTrials, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Panama. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the VaxTrials public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.